2-Vinylpyridine

CAS No. 100-69-6

2-Vinylpyridine( —— )

Catalog No. M19493 CAS No. 100-69-6

mainly used in synthetic pyridine-styrene-butadiene latex also used in the manufacture of silicon and Bestatin hydrochloride and other drugs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-Vinylpyridine
  • Note
    Research use only, not for human use.
  • Brief Description
    mainly used in synthetic pyridine-styrene-butadiene latex also used in the manufacture of silicon and Bestatin hydrochloride and other drugs.
  • Description
    mainly used in synthetic pyridine-styrene-butadiene latex also used in the manufacture of silicon and Bestatin hydrochloride and other drugs.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100-69-6
  • Formula Weight
    105.14
  • Molecular Formula
    C7H7N
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C=CC1=CC=CC=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang X et al. Inorg Chem. 2014 Dec 15;53(24):12986-3000.
molnova catalog
related products
  • CGRP (83-119), rat T...

    Calcitonin Gene Related Peptide (CGRP) (83-119), rat (TFA) is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor.

  • BMS-986251

    BMS-986251 is a Clinically Viable, Potent, and Selective RORγt Inverse Agonist.

  • Memantine

    Memantine, an amantadine derivative with some dopaminergic effects, has been proposed as an antiparkinson agent and has may be used to treat moderate to severe Alzheimer's disease. It acts on the glutamatergic system by blocking NMDA receptors.